Inactive Instrument

Other languages Zymergen Inc.

Equities

ZY

US98985X1000

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Zymergen Inc. Went Out of Business	Feb. 22
Motion for Exclusivity Period Extension Approved For Zymergen Inc.	Jan. 30
First Motion for Exclusivity Period Extension Filed by Zymergen Inc.	Jan. 21
Disclosure Statement Approved for Zymergen Inc.	Dec. 19
Motion for Joint Administration Approved for Zymergen Inc.	23-10-03
Motion for Joint Administration Filed by Zymergen Inc.	23-10-03
Zymergen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	23-01-27
Ginkgo Bioworks Holdings Closes Zymergen Acquisition	22-10-19
Zymergen Inc. Announces Executive Changes	22-10-19
Ginkgo Bioworks Holdings, Inc. completed the acquisition of Zymergen Inc. (NasdaqGS:ZY) from a group of shareholders.	22-10-18
Zymergen Says It Cut 80 More Jobs; Co-Founder Zach Serber Stepping Down as Chief Science Officer	22-08-25
Zymergen Inc. Announces Stepping Down of Zach Serber as Co-Founder and Chief Science Officer and A Member of It’S Board of Directors, Effective as of September 22, 2022	22-08-25
Zymergen Inc. Announces Further Reduction in Force	22-08-25
Zymergen Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15
Sector Update: Health Care Stocks Narrowly Staying on Positive Ground	22-07-25
Sector Update: Health Care Stocks Scratching Out Modest Advance	22-07-25
Zymergen to Terminate 80 Employees Under Initial Phase of Downsizing Program; Severance Costs Pegged at $4 Million	22-07-25
Ginkgo Bioworks to Acquire Zymergen in $300 Million All-Stock Deal; Buys Bayer's Biologics R&D Center for $83 Million	22-07-25
Sector Update: Health Care Stocks Edge Higher Premarket Monday	22-07-25
Ginkgo Bioworks to Acquire Zymergen in $300 Million All-Stock Deal; Buys Bayer's Biologics R&D Center for $83 Million	22-07-25

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Zymergen Inc.

Equities

ZY

US98985X1000

Other languages

Filters